Results 41 to 50 of about 3,132,176 (310)

Hypofractionated preoperative radiotherapy for high risk soft tissue sarcomas in a geriatric patient population

open access: yesRadiology and Oncology, 2021
Standard therapy for localised, resectable high risk soft tissue sarcomas consists of wide excision and radiotherapy over several weeks. This treatment schedule is hardly feasible in geriatric and frail patients.
Potkrajcic Vlatko   +7 more
doaj   +1 more source

Soft tissue tumors: Low grade fibromyxoid sarcoma [PDF]

open access: yes, 2005
Review on Soft tissue tumors: Low grade fibromyxoid sarcoma, with data on clinics, and the genes ...
Panagopoulos, I   +3 more
core   +1 more source

Current advances in radiotherapy for soft tissue sarcomas

open access: yesNowotwory, 2020
Radiotherapy (RT) is a part of the routine treatment of locally advanced or high-grade soft-tissue sarcomas (STS). However, RT has changed significantly over the last 20 years. Modern RT techniques have extended its potential application in STS treatment.
Mateusz J. Spałek, Aneta M. Borkowska
doaj   +1 more source

Wyniki leczenia operacyjnego chorych na chrzęstniakomięsaki miednicy z oszczędzeniem kończyny

open access: yesNowotwory, 2021
Analizie poddano 53 kolejnych chorych na chondrosarcoma (ChSa) kości miednicy i kości krzyżowej leczonych operacyjnie w Klinice Nowotworów Tkanek Miękkich, Kości i Czerniaków Narodowego Instytutu Onkologii im.
Andrzej Pieńkowski   +9 more
doaj   +1 more source

Targeting TIMM23 to overcome osteosarcoma chemoresistance

open access: yesCell Death and Disease
Osteosarcoma (OS) is a malignant tumor whose chemoresistance severely compromises therapeutic efficacy. This study aims to investigate the molecular mechanism by which TIMM23 mediates M2 polarization of macrophages through mitophagy and regulates TIMM23 ...
Zhiwei Tao   +5 more
doaj   +1 more source

Tebentafusp (IMCgp100) in the treatment of uveal melanoma — from preclinical evidence to clinical practice

open access: yesNowotwory
Tebentafusp (IMCgp100) is a novel bispecific immunotherapy that contains a specifically engineered soluble T-cellreceptor (TCR) capable of recognising the gp100 epitope on the surface of tumour cells presented by human leukocyteantigen-A*02:01 (HLA- A*02:
Piotr Remiszewski   +8 more
doaj   +1 more source

The Impact of the COVID‐19 Pandemic on Childhood Cancer Survival: A Population‐Based Assessment of Survival Patterns Between 2015 and 2023 in Germany

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Numerous international studies have reported declines in new cancer diagnoses, delayed diagnoses and disruptions in cancer treatment following the implementation of COVID‐19 pandemic public health measures, raising concerns that these effects may ultimately contribute to increased cancer mortality.
Friederike Erdmann   +8 more
wiley   +1 more source

Single-cell multi-omics elucidates the role of RPS27-RPS24 fusion gene in osteosarcoma chemoresistance and metabolic regulation

open access: yesCell Death Discovery
Osteosarcoma (OS) presents significant treatment challenges due to chemoresistance. This study explores the molecular mechanisms underlying chemoresistance in OS, focusing on the novel fusion gene RPS27-RPS24. Using single-cell multi-omics techniques, we
Zhiwei Tao   +5 more
doaj   +1 more source

Diagnostic Value of Serum LncRNAs for Bone Metastasis in Lung Cancer

open access: yesZhongliu Fangzhi Yanjiu, 2022
Objective To investigate the expression of lncRNA HOTAIR, HOTAIR, CRNDE and AFAP1-AS1 in lung cancer patients with bone metastasis (LCWBM), and to elucidate the diagnostic value of lncRNAs for LCWBM. Methods Serum was collected from 38 LCWBM patients and
ZHANG Peng   +5 more
doaj   +1 more source

Referral Patterns and Diagnostic Timeliness in Pediatric Cancer: A Hospital‐Based Study in Indonesia

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Timely diagnosis and treatment are critical for improving survival among children with cancer. In low‐ and middle‐income countries (LMICs), delays are common and may be influenced by fragmented referral pathways and diagnostic limitations.
Nur Melani Sari   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy